Is Viridian Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 07:59 PM IST
share
Share Via
As of August 26, 2025, Viridian Therapeutics, Inc. shows a bullish technical trend, supported by positive indicators like the weekly MACD and Bollinger Bands, despite mixed performance signals and underperformance against the S&P 500 over the past 1Y and 3Y.
As of 26 August 2025, the technical trend for Viridian Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from Bollinger Bands and daily moving averages. The KST is also bullish on a weekly basis, while the Dow Theory indicates a mildly bullish stance. However, the OBV shows a mixed signal with a mildly bullish weekly reading but a mildly bearish monthly reading.

In terms of performance, the stock has underperformed the S&P 500 over the 1Y and 3Y periods, with returns of -6.84% and -10.82% respectively, compared to the S&P 500's 17.14% and 70.41%. Over the 5Y period, the stock has outperformed with a return of 54.37% versus the S&P 500's 96.61%. Overall, the current technical stance is bullish, indicating a strengthening trend.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Viridian Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:12 AM IST
share
Share Via
What does Viridian Therapeutics, Inc. do?
Jun 22 2025 06:56 PM IST
share
Share Via
How big is Viridian Therapeutics, Inc.?
Jun 22 2025 06:10 PM IST
share
Share Via